Patrick D. Kirwin, Director at ProMIS Neurosciences Inc. (PMN), bought 4,000 shares at $5.92 ($24K) on 2022-08-17, disclosed to the SEC on 2022-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PMN | BUY | 2022-12-15 | $14K | — | Filing → |
| PMN | BUY | 2022-12-13 | $5K | — | Filing → |